Kerendia (finerenone)

$8,000.00

New drug (Bayer) for CKD in type 2 diabetes; FDA approved 2021. Premium brand.

Category: Tag: Brand:

Description

Kerendia (finerenone) is a prescription medication used to reduce the risk of kidney function decline, kidney failure, and heart-related complications in adults with chronic kidney disease (CKD) associated with type 2 diabetes. It works by blocking mineralocorticoid receptors, which helps decrease inflammation and fibrosis in the kidneys and heart.

Reviews

There are no reviews yet.

Be the first to review “Kerendia (finerenone)”

Your email address will not be published. Required fields are marked *